Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer

被引：6
|
作者：
Morganti, Stefania [1 ,2 ,3 ,4 ,5 ]
Tolaney, Sara M. [1 ,2 ,6 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA
[2] Dana Farber Brigham Canc Ctr, Breast Oncol Program, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Broad Inst & Harvard, Boston, MA USA
[5] Univ Milan, Ist Europeo Oncol, Dept Oncol & Hemato Oncol, Milan, Italy
[6] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 01期
关键词：
TNBC; Breast cancer; Immunotherapy; Biomarkers; PDL1; Immune checkpoint inhibitors; PEMBROLIZUMAB PLUS CHEMOTHERAPY; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; DOUBLE-BLIND; PLACEBO; ATEZOLIZUMAB; PACLITAXEL; MELANOMA; TNBC;
D O I：
10.1016/j.hoc.2022.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：133 / 150
页数：18
相关论文
共 50 条
  • [31] Update on the Treatment of Early-Stage Triple-Negative Breast Cancer
    Priyanka Sharma
    Current Treatment Options in Oncology, 2018, 19
  • [32] Update on the Treatment of Early-Stage Triple-Negative Breast Cancer
    Sharma, Priyanka
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (05)
  • [33] Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
    A Pinzon-Charry
    C S K Ho
    T Maxwell
    M A McGuckin
    C Schmidt
    C Furnival
    C M Pyke
    J A López
    British Journal of Cancer, 2007, 97 : 1251 - 1259
  • [34] Advances in the Management of Early-Stage Triple-Negative Breast Cancer
    Bhardwaj, Prarthna V.
    Wang, Yue
    Brunk, Elizabeth
    Spanheimer, Philip M.
    Abdou, Yara G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [35] Anxiety level of early- and late-stage prostate cancer patients
    Johanes, Charles
    Monoarfa, Richard Arie
    Ismail, Raden Irawati
    Umbas, Rainy
    PROSTATE INTERNATIONAL, 2013, 1 (04) : 177 - 182
  • [36] Clinical trials of immunotherapy in triple-negative breast cancer
    Frederick M. Howard
    Alexander T. Pearson
    Rita Nanda
    Breast Cancer Research and Treatment, 2022, 195 : 1 - 15
  • [37] Clinical trials of immunotherapy in triple-negative breast cancer
    Howard, Frederick M.
    Pearson, Alexander T.
    Nanda, Rita
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 195 (01) : 1 - 15
  • [38] Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
    Elizabeth, Melendez Solano
    Cristina, Stevens Barron Jazmin
    Christian, Chapa Gonzalez
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (04) : 431 - 439
  • [39] Immunotherapy in Triple-Negative Breast Cancer: Present and Future
    Kim, Isaac
    Sanchez, Katherine
    McArthur, Heather L.
    Page, David
    CURRENT BREAST CANCER REPORTS, 2019, 11 (04) : 259 - 271
  • [40] Updates on the preoperative immunotherapy for triple-negative breast cancer
    Hu, Hong
    Kaklamani, Virginia
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
12345